Daclatasvir

CAS 1009119-64-5

In Stock

Daclatasvir

Cat. No. STUB-API-DACLATASVIRCAS 1009119-64-5In Stock

Technical Data

Cat. No.STUB-API-DACLATASVIR

CAS1009119-64-5

Mol. FormulaC₄₀H₅₀N₈O₆

Mol. Weight738.89 g/mol

IUPACmethyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

SMILESCC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC

InChIInChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1

InChI KeyFKRSSPOQAMALKA-CUPIEXAXSA-N

Purity—

Description

Overview

Daclatasvir, sold under the trade name Daklinza, is a medication used in combination with other medications to treat hepatitis C. The other medications used in combination include sofosbuvir, ribavirin, and interferon, vary depending on the virus type and whether the person has cirrhosis

Anant Labs manufacture and furnish high quality Daclatasvir impurities for global markets. Our Daclatasvir EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Synonyms

Daclatasvir1009119-64-5BMS-790052BMS790052BMS 790052EBP 883Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl estermethyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamateEBP-883LI2427F9CI

Browse APIs A–Z